查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594490

次世代定序仪市场：按技术、产品类型、应用和最终用户划分 - 2025-2030 年全球预测

Next Generation Sequencing Market by Technology (Targeted Sequencing & Re-Sequencing, Whole Exome Sequencing, Whole Genome Sequencing), Product Type (Consumables, Platforms, Services), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

次世代定序仪市场2023年估值为177.3亿美元，预计2024年将达到213.8亿美元，复合年增长率为23.61%，到2030年将达到782.1亿美元。

次世代定序仪(NGS) 是一组遗传技术，能够对整个基因组或 DNA 或 RNA 的特定区域进行快速定序，为遗传学和疾病检测提供重要见解。 NGS 的需求在于其能够高效、低成本地提供高通量测序资料，从而能够在个人化医疗、遗传研究甚至农业基因组学中得到应用。 NGS 主要用于研究环境、临床诊断、生殖医学、药物基因组学和疾病管理。最终用途包括学术界、生技公司、製药和医疗机构。关键的成长要素包括定序技术的进步、遗传疾病盛行率的上升以及公共和私营部门对基因组学投资的增加。对个人化医疗以及肿瘤学和传染病检查新应用的需求迅速增长，代表着一个重大的商机。为了利用这些优势，公司应该专注于开发具有成本效益、更快、更准确的定序技术，并扩展到正在投资基因组研究基础设施的新兴市场，例如亚太地区。然而，市场成长面临着诸如高昂的初始设定成本、有关遗传资料隐私的伦理问题以及监管障碍（尤其是在临床应用方面）等挑战。资料解释的局限性和技术纯熟劳工的缺乏也阻碍了快速采用。创新应着重于整合人工智慧和机器学习进行资料分析、开发更直观的生物资讯学工具以及提高序列组装准确性。市场高度活跃，反映出疫情后技术的快速进步和公共卫生优先事项的变化，并且需要敏捷性和持续的研发投资才能保持竞争力。从策略上讲，公司应考虑与学术研究机构合作并扩大其服务范围，包括全面的基因组资料解释服务，以解决 NGS效用的关键瓶颈。

主要市场统计
基准年[2023] 177.3亿美元
预测年份 [2024] 213.8亿美元
预测年份 [2030] 782.1亿美元
复合年增长率（%） 23.61%

市场动态：揭示快速发展的次世代定序仪市场的关键市场洞察

供需的动态交互作用正在改变次世代定序仪市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • NGS 技术在临床诊断中的广泛采用。
    • NGS 应用扩大，肿瘤学研究经费激增
    • 农业领域越来越多地采用分析植物遗传潜力的方法
  • 市场限制因素
    • 缺乏计算资源和人员来分析和解释临床资料
  • 市场机会
    • 继续专注于开发新技术和基于 NGS 的产品商业化
    • 政府和私营部门增加对大规模测序技术的支持
  • 市场挑战
    • 关于次世代定序仪资料保护的道德和隐私问题

波特五力：驾驭次世代定序仪市场的策略工具

波特的五力架构是了解次世代定序仪市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对次世代定序仪市场的影响

外部宏观环境因素在塑造次世代定序仪市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解次世代定序仪市场的竞争状况

次世代定序仪市场的详细市场占有率分析提供了对供应商绩效的全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵次世代定序仪供应商市场绩效评估

FPNV定位矩阵是评估次世代定序仪市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了次世代定序仪市场的成功之路

次世代定序仪市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于快速结果和快速处理，NGS 技术在临床诊断中广泛采用
      • 扩大 NGS 的应用并迅速增加肿瘤学研究的资金
      • 农业领域越来越多地采用分析植物遗传潜力的方法
    • 抑制因素
      • 缺乏计算资源和人员来分析和解释临床资料
    • 机会
      • 继续专注于开发新技术和基于 NGS 的产品商业化
      • 政府和私营部门增加对大规模定序技术的支持
    • 任务
      • 关于次世代定序仪资料保护的道德和隐私问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章次世代定序仪市场：依技术分类

  • 标靶定序和定序
  • 全EXOME定序
  • 全基因组序列分析

第七章次世代定序仪市场：依产品类型

  • 消耗品
  • 平台
  • 服务

第 8 章次世代定序仪市场：按应用分类

  • 农业
  • 动物科学和兽医研究
  • 诊断
  • 药物发现

第 9 章次世代定序仪市场：按最终用户划分

  • 学术研究所
  • 临床实验室
  • 合约调查机构
  • 医院/诊所
  • 製药和生物技术公司

第10章 美洲次世代定序仪市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区次世代定序仪市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲次世代定序仪市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • QIAGEN 完成对 Verogen 的收购，透过 NGS 技术加强人类 ID/法医学领先地位。
    • QIAGEN 和 Helix 开始建立独家伙伴关係，以推进遗传疾病的次世代定序伴同性诊断。
    • 安捷伦宣布收​​购 Avida Biomed，该公司是癌症研究高性能 NGS靶向序列捕获的开发商。
    • Integrated DNA Technologies 从 Invitae Corporation 收购了 ArcherDX次世代定序仪研究检测。
    • 华大智造旗下Complete Genomics在ASHG年会上发表了次世代定序平台。
    • 澳洲华大基因 (BGI Australia) 获得 NATA 临床全EXOME序认证。
    • ASM 宣布 CDC 资助的基因组监测培训计划。
    • NGS 生物安全测试和生物製药表征领域的领先专家在美国主要市场推出了新功能。
    • Illumina 发布下一代 DNA 定序仪。
    • Thermo Fisher Scientific 推出了次世代定序仪器。
    • Illumina 和 Trivitron 联手加速印度患者的疾病检测和诊断。
  • 战略分析和建议

公司名单

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • ATDBio Ltd.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • BIO3 SCIENTIFIC SDN BHD
  • bioMerieux SA
  • BioVendor-Laboratorni medicina as
  • Cambridge Bioscience Limited
  • CD Genomics
  • CeGaT GmbH
  • Charles River Laboratories, Inc.
  • DNAnexus, Inc.
  • DNASTAR, Inc.
  • ELEMENT BIOSCIENCES
  • Enzo Life Sciences, Inc.
  • Eppendorf SE
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Fraunhofer-Gesellschaft
  • GENEWIZ
  • Genomatix
  • GenPath
  • GenScript Biotech Corporation
  • GRAIL, LLC
  • Hamilton Company
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Invivoscribe, Inc.
  • iRepertoire, Inc.
  • LabMal
  • Macrogen, Inc.
  • Medigene Sdn Bhd.
  • Merck KGaA
  • NanoString Technologies, Inc.
  • Neoscience
  • Norgen Biotek Corp.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California, Inc.
  • PathoQuest
  • PCR Biosystems Ltd.
  • Perkin Elmer, Inc.
  • Promega Corporation
  • PT Pandu Biosains
  • Qiagen NV
  • Resolution Bioscience, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4312A385A68A

The Next Generation Sequencing Market was valued at USD 17.73 billion in 2023, expected to reach USD 21.38 billion in 2024, and is projected to grow at a CAGR of 23.61%, to USD 78.21 billion by 2030.

Next Generation Sequencing (NGS) represents a suite of genetic technologies that allow rapid sequencing of entire genomes or specific areas of DNA or RNA, offering significant insights into genetics and disease detection. Its necessity is anchored in its ability to provide high-throughput sequencing data efficiently and at decreasing costs, enabling advances in personalized medicine, genetic research, and even applications in agrigenomics. NGS is primarily used in research settings, clinical diagnostics, reproductive health, pharmacogenomics, and disease management. The end-use spectrum spans academia, biotechnology firms, pharmaceuticals, and healthcare facilities. Key growth factors include advancements in sequencing technology, rising prevalence of genetic disorders, and increasing investments in genomics by both public and private sectors. The surge in demand for personalized medicine and new applications in oncology and infectious disease testing are significant opportunities. To capitalize on these, businesses should focus on developing cost-effective, faster, and more accurate sequencing technologies and expand into emerging markets that are investing in genomic research infrastructures, like APAC. Nonetheless, market growth faces challenges such as high initial setup costs, ethical concerns regarding genetic data privacy, and regulatory hurdles, especially concerning clinical applications. Limitations in data interpretation and lack of skilled workforce also impede rapid adoption. Innovations should focus on AI and machine learning integration for data analysis, development of more intuitive bioinformatics tools, and improvements in sequence assembly accuracy. The market is highly dynamic, reflecting rapid technological advances and shifting public health priorities post-pandemic, necessitating agility and continued investment in R&D to remain competitive. Strategically, firms should consider partnerships with academic research institutions and expansion of service offerings to include comprehensive genomic data interpretation services, addressing a key bottleneck in NGS utility.

KEY MARKET STATISTICS
Base Year [2023] USD 17.73 billion
Estimated Year [2024] USD 21.38 billion
Forecast Year [2030] USD 78.21 billion
CAGR (%) 23.61%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Next Generation Sequencing Market

The Next Generation Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Extensive adoption of NGS technologies in clinical diagnostics due to rapid result time and faster processin
    • Increased application of NGS and exponential availability of funds for oncology research
    • Emerging adoption in the agriculture sector to analyze the genetic potential of plants
  • Market Restraints
    • Lack of the computational resources and staffing to analyze and interpret clinical data
  • Market Opportunities
    • Continuous focus on new technology development and commercialization of NGS based products
    • Increased support from government and private sector for large scale sequencing technology
  • Market Challenges
    • Ethical and privacy concerns related to next generation sequencing data protection

Porter's Five Forces: A Strategic Tool for Navigating the Next Generation Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Next Generation Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Next Generation Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Next Generation Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Next Generation Sequencing Market

A detailed market share analysis in the Next Generation Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Next Generation Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Next Generation Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Next Generation Sequencing Market

A strategic analysis of the Next Generation Sequencing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Next Generation Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., ATDBio Ltd., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., BIO3 SCIENTIFIC SDN BHD, bioMerieux S.A., BioVendor-Laboratorni medicina a.s, Cambridge Bioscience Limited, CD Genomics, CeGaT GmbH, Charles River Laboratories, Inc., DNAnexus, Inc., DNASTAR, Inc., ELEMENT BIOSCIENCES, Enzo Life Sciences, Inc., Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Fraunhofer-Gesellschaft, GENEWIZ, Genomatix, GenPath, GenScript Biotech Corporation, GRAIL, LLC, Hamilton Company, Illumina, Inc., Integrated DNA Technologies, Inc., Invivoscribe, Inc., iRepertoire, Inc., LabMal, Macrogen, Inc., Medigene Sdn Bhd., Merck KGaA, NanoString Technologies, Inc., Neoscience, Norgen Biotek Corp., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., PathoQuest, PCR Biosystems Ltd., Perkin Elmer, Inc., Promega Corporation, PT Pandu Biosains, Qiagen N.V., Resolution Bioscience, Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Next Generation Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Targeted Sequencing & Re-Sequencing, Whole Exome Sequencing, and Whole Genome Sequencing.
  • Based on Product Type, market is studied across Consumables, Platforms, and Services.
  • Based on Application, market is studied across Agriculture, Animal science & Veterinary Research, Diagnostics, and Drug Discovery.
  • Based on End User, market is studied across Academic & Research Institutes, Clinical Laboratories, Contract Research Organization, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Extensive adoption of NGS technologies in clinical diagnostics due to rapid result time and faster processin
      • 5.1.1.2. Increased application of NGS and exponential availability of funds for oncology research
      • 5.1.1.3. Emerging adoption in the agriculture sector to analyze the genetic potential of plants
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of the computational resources and staffing to analyze and interpret clinical data
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous focus on new technology development and commercialization of NGS based products
      • 5.1.3.2. Increased support from government and private sector for large scale sequencing technology
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical and privacy concerns related to next generation sequencing data protection
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Next Generation Sequencing Market, by Technology

  • 6.1. Introduction
  • 6.2. Targeted Sequencing & Re-Sequencing
  • 6.3. Whole Exome Sequencing
  • 6.4. Whole Genome Sequencing

7. Next Generation Sequencing Market, by Product Type

  • 7.1. Introduction
  • 7.2. Consumables
  • 7.3. Platforms
  • 7.4. Services

8. Next Generation Sequencing Market, by Application

  • 8.1. Introduction
  • 8.2. Agriculture
  • 8.3. Animal science & Veterinary Research
  • 8.4. Diagnostics
  • 8.5. Drug Discovery

9. Next Generation Sequencing Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Clinical Laboratories
  • 9.4. Contract Research Organization
  • 9.5. Hospitals & Clinics
  • 9.6. Pharmaceutical & Biotechnology Companies

10. Americas Next Generation Sequencing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Next Generation Sequencing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Next Generation Sequencing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. QIAGEN completes acquisition of Verogen, strengthening leadership in Human ID / Forensics with NGS technologies.
    • 13.3.2. QIAGEN and Helix Launch Exclusive Partnership to Advance Next-Generation Sequencing Companion Diagnostics in Hereditary Diseases.
    • 13.3.3. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research.
    • 13.3.4. Integrated DNA Technologies Acquires ArcherDX Next Generation Sequencing Research Assays from Invitae Corporation.
    • 13.3.5. Complete Genomics, part of MGI, Announces Next-Generation Sequencing Platforms at ASHG Annual Meeting.
    • 13.3.6. BGI Australia receives NATA certification for clinical whole exome sequencing.
    • 13.3.7. ASM Announces CDC-Funded Genomic Surveillance Training Program.
    • 13.3.8. The Leading Experts in NGS Biosafety Testing and Characterization of Biopharmaceuticals Launch New Capabilities in the Critical U.S. Market.
    • 13.3.9. Illumina launches next-generation DNA sequencers.
    • 13.3.10. Thermo Fisher Scientific Launches CE-IVD Marked Next-Generation Sequencing Instrument for Use in Clinical Labs.
    • 13.3.11. Illumina and Trivitron Partner to Accelerate Disease Detection and Diagnosis for Patients in India.
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. ATDBio Ltd.
  • 4. BGI Genomics Co., Ltd.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. BIO3 SCIENTIFIC SDN BHD
  • 7. bioMerieux S.A.
  • 8. BioVendor-Laboratorni medicina a.s
  • 9. Cambridge Bioscience Limited
  • 10. CD Genomics
  • 11. CeGaT GmbH
  • 12. Charles River Laboratories, Inc.
  • 13. DNAnexus, Inc.
  • 14. DNASTAR, Inc.
  • 15. ELEMENT BIOSCIENCES
  • 16. Enzo Life Sciences, Inc.
  • 17. Eppendorf SE
  • 18. Eurofins Scientific SE
  • 19. F. Hoffmann-La Roche Ltd.
  • 20. Fraunhofer-Gesellschaft
  • 21. GENEWIZ
  • 22. Genomatix
  • 23. GenPath
  • 24. GenScript Biotech Corporation
  • 25. GRAIL, LLC
  • 26. Hamilton Company
  • 27. Illumina, Inc.
  • 28. Integrated DNA Technologies, Inc.
  • 29. Invivoscribe, Inc.
  • 30. iRepertoire, Inc.
  • 31. LabMal
  • 32. Macrogen, Inc.
  • 33. Medigene Sdn Bhd.
  • 34. Merck KGaA
  • 35. NanoString Technologies, Inc.
  • 36. Neoscience
  • 37. Norgen Biotek Corp.
  • 38. Oxford Nanopore Technologies PLC
  • 39. Pacific Biosciences of California, Inc.
  • 40. PathoQuest
  • 41. PCR Biosystems Ltd.
  • 42. Perkin Elmer, Inc.
  • 43. Promega Corporation
  • 44. PT Pandu Biosains
  • 45. Qiagen N.V.
  • 46. Resolution Bioscience, Inc.
  • 47. Takara Bio Inc.
  • 48. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. NEXT GENERATION SEQUENCING MARKET RESEARCH PROCESS
  • FIGURE 2. NEXT GENERATION SEQUENCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. NEXT GENERATION SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. NEXT GENERATION SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEXT GENERATION SEQUENCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEXT GENERATION SEQUENCING MARKET DYNAMICS
  • TABLE 7. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING & RE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY ANIMAL SCIENCE & VETERINARY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. NEXT GENERATION SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 195. NEXT GENERATION SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023